TY - JOUR AU - Kikuchi, E. AU - Fujimoto, H. AU - Mizutani, Y. AU - Okajima, E. AU - Koga, H. AU - Hinotsu, S. PY - 2009 DA - 2009// TI - Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association JO - Int J Urol VL - 16 UR - https://doi.org/10.1111/j.1442-2042.2008.02235.x DO - 10.1111/j.1442-2042.2008.02235.x ID - Kikuchi2009 ER - TY - JOUR AU - Li, K. AU - Lin, T. AU - Fan, X. AU - Duan, Y. AU - Huang, J. PY - 2013 DA - 2013// TI - Diagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: a systematic review and meta-analysis JO - Int J Urol VL - 20 UR - https://doi.org/10.1111/j.1442-2042.2012.03211.x DO - 10.1111/j.1442-2042.2012.03211.x ID - Li2013 ER - TY - JOUR AU - Lamm, D. L. AU - Blumenstein, B. A. AU - Crissman, J. D. AU - Montie, J. E. AU - Gottesman, J. E. AU - Lowe, B. A. PY - 2000 DA - 2000// TI - Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study JO - J Urol VL - 163 UR - https://doi.org/10.1016/S0022-5347(05)67707-5 DO - 10.1016/S0022-5347(05)67707-5 ID - Lamm2000 ER - TY - JOUR AU - Bohle, A. AU - Jocham, D. AU - Bock, P. R. PY - 2003 DA - 2003// TI - Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity JO - J Urol VL - 169 UR - https://doi.org/10.1016/S0022-5347(05)64043-8 DO - 10.1016/S0022-5347(05)64043-8 ID - Bohle2003 ER - TY - JOUR AU - Malmstrom, P. U. AU - Sylvester, R. J. AU - Crawford, D. E. AU - Friedrich, M. AU - Krege, S. AU - Rintala, E. PY - 2009 DA - 2009// TI - An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guerin for non-muscle-invasive bladder cancer JO - Eur Urol VL - 56 UR - https://doi.org/10.1016/j.eururo.2009.04.038 DO - 10.1016/j.eururo.2009.04.038 ID - Malmstrom2009 ER - TY - JOUR AU - Sylvester, R. J. AU - Brausi, M. A. AU - Kirkels, W. J. AU - Hoeltl, W. AU - Calais Da Silva, F. AU - Powell, P. H. PY - 2010 DA - 2010// TI - Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guerin, and bacillus Calmette-Guerin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder JO - Eur Urol VL - 57 UR - https://doi.org/10.1016/j.eururo.2009.12.024 DO - 10.1016/j.eururo.2009.12.024 ID - Sylvester2010 ER - TY - JOUR AU - Takeda, T. AU - Kikuchi, E. AU - Yuge, K. AU - Matsumoto, K. AU - Miyajima, A. AU - Nakagawa, K. PY - 2009 DA - 2009// TI - Discontinuance of bacille Calmette-Guerin instillation therapy for nonmuscle-invasive bladder cancer has negative effect on tumor recurrence JO - Urology VL - 73 UR - https://doi.org/10.1016/j.urology.2008.12.039 DO - 10.1016/j.urology.2008.12.039 ID - Takeda2009 ER - TY - JOUR AU - Kurth, K. H. AU - Bouffioux, C. AU - Sylvester, R. AU - Meijden, A. P. AU - Oosterlinck, W. AU - Brausi, M. PY - 2000 DA - 2000// TI - Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group JO - Eur Urol VL - 37 UR - https://doi.org/10.1159/000052386 DO - 10.1159/000052386 ID - Kurth2000 ER - TY - JOUR AU - Wientjes, M. G. AU - Badalament, R. A. AU - Wang, R. C. AU - Hassan, F. AU - Au, J. L. PY - 1993 DA - 1993// TI - Penetration of mitomycin C in human bladder JO - Cancer Res VL - 53 ID - Wientjes1993 ER - TY - JOUR AU - Wientjes, M. G. AU - Badalament, R. A. AU - Au, J. L. PY - 1996 DA - 1996// TI - Penetration of intravesical doxorubicin in human bladders JO - Cancer Chemother Pharmacol VL - 37 UR - https://doi.org/10.1007/s002800050426 DO - 10.1007/s002800050426 ID - Wientjes1996 ER - TY - JOUR AU - Galsky, M. D. PY - 2005 DA - 2005// TI - The role of taxanes in the management of bladder cancer JO - Oncologist VL - 10 UR - https://doi.org/10.1634/theoncologist.10-10-792 DO - 10.1634/theoncologist.10-10-792 ID - Galsky2005 ER - TY - JOUR AU - Maru, S. AU - Abe, T. AU - Shinohara, N. AU - Sazawa, A. AU - Maruyama, S. AU - Harabayashi, T. PY - 2012 DA - 2012// TI - Influence of baseline renal function and dose reduction of nephrotoxic chemotherapeutic agents on the outcome of metastatic urothelial carcinoma: a retrospective study JO - Int J Urol VL - 19 UR - https://doi.org/10.1111/j.1442-2042.2011.02913.x DO - 10.1111/j.1442-2042.2011.02913.x ID - Maru2012 ER - TY - JOUR AU - Gelderblom, H. AU - Verweij, J. AU - Nooter, K. AU - Sparreboom, A. PY - 2001 DA - 2001// TI - Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation JO - Eur J Cancer VL - 37 UR - https://doi.org/10.1016/S0959-8049(01)00171-X DO - 10.1016/S0959-8049(01)00171-X ID - Gelderblom2001 ER - TY - JOUR AU - Weiss, R. B. AU - Donehower, R. C. AU - Wiernik, P. H. AU - Ohnuma, T. AU - Gralla, R. J. AU - Trump, D. L. PY - 1990 DA - 1990// TI - Hypersensitivity reactions from taxol JO - J Clin Oncol VL - 8 ID - Weiss1990 ER - TY - JOUR AU - Lorenz, W. AU - Reimann, H. J. AU - Schmal, A. AU - Dormann, P. AU - Schwarz, B. AU - Neugebauer, E. PY - 1977 DA - 1977// TI - Histamine release in dogs by Cremophor E1 and its derivatives: oxethylated oleic acid is the most effective constituent JO - Agents Actions VL - 7 UR - https://doi.org/10.1007/BF01964882 DO - 10.1007/BF01964882 ID - Lorenz1977 ER - TY - JOUR AU - Knemeyer, I. AU - Wientjes, M. G. AU - Au, J. L. PY - 1999 DA - 1999// TI - Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment JO - Cancer Chemother Pharmacol VL - 44 UR - https://doi.org/10.1007/s002800050973 DO - 10.1007/s002800050973 ID - Knemeyer1999 ER - TY - JOUR AU - Ishihara, K. AU - Iwasaki, Y. AU - Nakabayashi, N. PY - 1999 DA - 1999// TI - Polymeric lipid nanosphere consisting of water-soluble poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) JO - Polym J VL - 31 UR - https://doi.org/10.1295/polymj.31.1231 DO - 10.1295/polymj.31.1231 ID - Ishihara1999 ER - TY - JOUR AU - Konno, T. AU - Watanabe, J. AU - Ishihara, K. PY - 2003 DA - 2003// TI - Enhanced solubility of paclitaxel using water-soluble and biocompatible 2-methacryloyloxyethyl phosphorylcholine polymers JO - J Biomed Mater Res A VL - 65 UR - https://doi.org/10.1002/jbm.a.10481 DO - 10.1002/jbm.a.10481 ID - Konno2003 ER - TY - JOUR AU - Wada, M. AU - Jinno, H. AU - Ueda, M. AU - Ikeda, T. AU - Kitajima, M. AU - Konno, T. PY - 2007 DA - 2007// TI - Efficacy of an MPC-BMA co-polymer as a nanotransporter for paclitaxel JO - Anticancer Res VL - 27 ID - Wada2007 ER - TY - JOUR AU - Goda, T. AU - Goto, Y. AU - Ishihara, K. PY - 2010 DA - 2010// TI - Cell-penetrating macromolecules: direct penetration of amphipathic phospholipid polymers across plasma membrane of living cells JO - Biomaterials VL - 31 UR - https://doi.org/10.1016/j.biomaterials.2009.11.095 DO - 10.1016/j.biomaterials.2009.11.095 ID - Goda2010 ER - TY - JOUR AU - Horiguchi, Y. AU - Kikuchi, E. AU - Ozu, C. AU - Nishiyama, T. AU - Oyama, M. AU - Horinaga, M. PY - 2008 DA - 2008// TI - Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatments JO - Hum Cell VL - 21 UR - https://doi.org/10.1111/j.1749-0774.2008.00055.x DO - 10.1111/j.1749-0774.2008.00055.x ID - Horiguchi2008 ER - TY - JOUR AU - Kikuchi, E. AU - Menendez, S. AU - Ozu, C. AU - Ohori, M. AU - Cordon-Cardo, C. AU - Logg, C. R. PY - 2007 DA - 2007// TI - Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-07-0151 DO - 10.1158/1078-0432.CCR-07-0151 ID - Kikuchi2007 ER - TY - JOUR AU - Matsushima, M. AU - Horinaga, M. AU - Fukuyama, R. AU - Yanaihara, H. AU - Kikuchi, E. AU - Kawachi, M. PY - 2011 DA - 2011// TI - Enhanced antitumor effect of combination intravesical mitomycin C and bacillus Calmette-Guerin therapy in an orthotopic bladder cancer model JO - Oncol Lett VL - 2 ID - Matsushima2011 ER - TY - JOUR AU - Matsumoto, K. AU - Kikuchi, E. AU - Horinaga, M. AU - Takeda, T. AU - Miyajima, A. AU - Nakagawa, K. PY - 2011 DA - 2011// TI - Intravesical interleukin-15 gene therapy in an orthotopic bladder cancer model JO - Hum Gene Ther VL - 22 UR - https://doi.org/10.1089/hum.2011.013 DO - 10.1089/hum.2011.013 ID - Matsumoto2011 ER - TY - JOUR AU - Ishihara, K. PY - 1990 DA - 1990// TI - Preparation of phospholipid polymers and their properties as polymer hydrogel membrane JO - Polym J VL - 22 UR - https://doi.org/10.1295/polymj.22.355 DO - 10.1295/polymj.22.355 ID - Ishihara1990 ER - TY - JOUR AU - Rosato, A. AU - Banzato, A. AU - Luca, G. AU - Renier, D. AU - Bettella, F. AU - Pagano, C. PY - 2006 DA - 2006// TI - HYTAD1-p20: a new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer JO - Urol Oncol VL - 24 UR - https://doi.org/10.1016/j.urolonc.2005.08.020 DO - 10.1016/j.urolonc.2005.08.020 ID - Rosato2006 ER - TY - JOUR AU - Visage, C. AU - Rioux-Leclercq, N. AU - Haller, M. AU - Breton, P. AU - Malavaud, B. AU - Leong, K. PY - 2004 DA - 2004// TI - Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer JO - J Urol VL - 171 UR - https://doi.org/10.1097/01.ju.0000103922.12319.59 DO - 10.1097/01.ju.0000103922.12319.59 ID - Visage2004 ER - TY - JOUR AU - Lu, Z. AU - Yeh, T. K. AU - Tsai, M. AU - Au, J. L. AU - Wientjes, M. G. PY - 2004 DA - 2004// TI - Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-04-1443 DO - 10.1158/1078-0432.CCR-04-1443 ID - Lu2004 ER - TY - JOUR AU - Soma, D. AU - Kitayama, J. AU - Konno, T. AU - Ishihara, K. AU - Yamada, J. AU - Kamei, T. PY - 2009 DA - 2009// TI - Intraperitoneal administration of paclitaxel solubilized with poly(2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) for peritoneal dissemination of gastric cancer JO - Cancer Sci VL - 100 UR - https://doi.org/10.1111/j.1349-7006.2009.01265.x DO - 10.1111/j.1349-7006.2009.01265.x ID - Soma2009 ER -